I am far from a short you old cogger. I am not a s
Post# of 153880
(Total Views: 838)
Posted On: 09/13/2020 4:38:51 PM
Re: BBCOldCodger #55575
I am far from a short you old cogger. I am not a spry guy myself. You can call me short if you feel that helps your argument with that 3rd rate cancer therapy. lol... I also have to say I feel that all drugs if they provide relief or help in any way have value. Maybe Trodelvy has value? Maybe it gets used after everything is exhausted? Maybe new information is released that gives it a better chance as a first use drug. I am happy for your investment and the rise you will see tomorrow when the news of Gilead buyout hits the stock price. GLTU.
My main point was market share and use and I believe Leronlimab should have the market share when it happens to get approved with that excellent safety record and mechanism of action that reduces CTC to zero and maintains that zero CTC. I hope and would like believe it will bridge the gap for a partial cure by stopping all future metastasis. Hopefully when used with other cancer treatments it might just be combined into a cure for all the solid tumor cancers. That remains to be seen but just think if we could be a part of curing some of the nastiest deadly cancers out there.
All I can say to you is that Leronlimab is going to be an Achilles heel for many Big Pharma companies if everything we know to be true actually holds to be true. I believe in our CEO Nader and have never said a cross word about Nader or the CYDY management team.
By the way, I have a 5 figure amount of stock and average $.34/share. Had my one year anniversary of ownership last month. I consider myself long and I have never sold a share of CYDY since my original purchase. Why you might ask. It’s because I believe in Leronlimab and it’s mechanism of action not just working for one indication but many anti inflammatory mechanisms of action and immune modulations and so likely working for many diseases. I am all in because I believe. Hoping for a great next 30 days! With two approvals and an uplisting and a cancer BTD filed. Not necessarily in any specific order. I will take all 4 in any order they come. Good luck to us all...
My main point was market share and use and I believe Leronlimab should have the market share when it happens to get approved with that excellent safety record and mechanism of action that reduces CTC to zero and maintains that zero CTC. I hope and would like believe it will bridge the gap for a partial cure by stopping all future metastasis. Hopefully when used with other cancer treatments it might just be combined into a cure for all the solid tumor cancers. That remains to be seen but just think if we could be a part of curing some of the nastiest deadly cancers out there.
All I can say to you is that Leronlimab is going to be an Achilles heel for many Big Pharma companies if everything we know to be true actually holds to be true. I believe in our CEO Nader and have never said a cross word about Nader or the CYDY management team.
By the way, I have a 5 figure amount of stock and average $.34/share. Had my one year anniversary of ownership last month. I consider myself long and I have never sold a share of CYDY since my original purchase. Why you might ask. It’s because I believe in Leronlimab and it’s mechanism of action not just working for one indication but many anti inflammatory mechanisms of action and immune modulations and so likely working for many diseases. I am all in because I believe. Hoping for a great next 30 days! With two approvals and an uplisting and a cancer BTD filed. Not necessarily in any specific order. I will take all 4 in any order they come. Good luck to us all...
(5)
(1)